2022 - Research.com Genetics and Molecular Biology in Singapore Leader Award
Member of the European Molecular Biology Organization (EMBO)
His primary areas of investigation include Peroxisome proliferator-activated receptor, Receptor, Endocrinology, Internal medicine and Nuclear receptor. The subject of his Peroxisome proliferator-activated receptor research is within the realm of Biochemistry. His study in Receptor is interdisciplinary in nature, drawing from both Transcription factor, Cell growth and Epidermis, Cell biology.
As a member of one scientific family, he mostly works in the field of Endocrinology, focusing on Fatty liver and, on occasion, Fatty acid homeostasis and Steatosis. In his study, Tumor necrosis factor alpha is inextricably linked to Cancer research, which falls within the broad field of Internal medicine. Walter Wahli has researched Nuclear receptor in several fields, including Coactivator, Peroxisome proliferator, Phylogenetics and SUPERFAMILY.
Walter Wahli focuses on Peroxisome proliferator-activated receptor, Internal medicine, Endocrinology, Receptor and Nuclear receptor. His Peroxisome proliferator-activated receptor research integrates issues from Peroxisome proliferator-activated receptor delta, Transcription factor, Peroxisome proliferator-activated receptor alpha and Cell biology. His work on Inflammation, Adipocyte, White adipose tissue and Fatty acid metabolism as part of general Internal medicine research is often related to FGF21, thus linking different fields of science.
As part of his studies on Endocrinology, Walter Wahli often connects relevant subjects like Fatty liver. His work in the fields of Receptor, such as Peroxisome, overlaps with other areas such as Fibrate. His Nuclear receptor study combines topics in areas such as Regulation of gene expression and Keratinocyte.
Walter Wahli mostly deals with Internal medicine, Peroxisome proliferator-activated receptor, Endocrinology, Receptor and Cell biology. Within one scientific family, Walter Wahli focuses on topics pertaining to Fatty acid under Internal medicine, and may sometimes address concerns connected to Liver cell. His Peroxisome proliferator-activated receptor research is multidisciplinary, relying on both Steatosis, Inflammation, Transcription factor, Downregulation and upregulation and Fatty liver.
In general Endocrinology study, his work on Lipid metabolism and Skeletal muscle often relates to the realm of FGF21, thereby connecting several areas of interest. His Receptor research incorporates elements of Nuclear receptor, Carbohydrate metabolism and Angiogenesis. His studies in Cell biology integrate themes in fields like Insulin receptor, Cell culture, Biogenesis and Gene expression.
His main research concerns Internal medicine, Endocrinology, Peroxisome proliferator-activated receptor, Receptor and Fatty liver. His research on Internal medicine frequently connects to adjacent areas such as Gut flora. Walter Wahli has researched Endocrinology in several fields, including Neuromuscular junction and Downregulation and upregulation.
His Peroxisome proliferator-activated receptor study combines topics from a wide range of disciplines, such as Peroxisome, Lipid metabolism and Fatty acid metabolism. The Peroxisome study combines topics in areas such as Physiology and Cell biology. His research investigates the link between Receptor and topics such as Transcription factor that cross with problems in Knockout mouse and PPAR agonist.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Peroxisome proliferator-activated receptors: nuclear control of metabolism.
Béatrice Desvergne;Walter Wahli.
Endocrine Reviews (1999)
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
O Braissant;F Foufelle;C Scotto;M Dauça.
Endocrinology (1996)
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
Steven A. Kliewer;Scott S. Sundseth;Stacey A. Jones;Peter J. Brown.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Roles of PPARs in health and disease.
Sander Kersten;Béatrice Desvergne;Walter Wahli.
Nature (2000)
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Sander Kersten;Josiane Seydoux;Jeffrey M. Peters;Frank J. Gonzalez.
Journal of Clinical Investigation (1999)
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Christine Dreyer;Grigorios Krey;Hansjörg Keller;Francoise Givel.
Cell (1992)
The PPARalpha-leukotriene B4 pathway to inflammation control.
Pallavi R. Devchand;Hansjörg Keller;Jeffrey Maurice Peters;Manuel Vazquez.
Nature (1996)
Fatty Acids, Eicosanoids, and Hypolipidemic Agents Identified as Ligands of Peroxisome Proliferator-Activated Receptors by Coactivator-Dependent Receptor Ligand Assay
Grigorios Krey;Olivier Braissant;Fabienne L’Horset;Eric Kalkhoven.
Molecular Endocrinology (1997)
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Liliane Michalik;Johan Auwerx;Joel P. Berger;V. Krishna Chatterjee.
Pharmacological Reviews (2006)
Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers.
Hansjorg Keller;Christine Dreyer;Jeffrey Medin;Abderrahim Mahfoudi.
Proceedings of the National Academy of Sciences of the United States of America (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Lausanne
University of Lausanne
Nanyang Technological University
Wageningen University & Research
Centre national de la recherche scientifique, CNRS
École Polytechnique Fédérale de Lausanne
Institut Pasteur
University of British Columbia
University Hospital of Lausanne
Inserm : Institut national de la santé et de la recherche médicale
University of Lorraine
Luleå University of Technology
Lawrence Berkeley National Laboratory
Beijing University of Chemical Technology
Aarhus University
Nagoya University
Buck Institute for Research on Aging
National University of La Plata
University of British Columbia
University of Washington
Cardiff University
University of Queensland
University College London
Centers for Disease Control and Prevention
University of Oslo
University of Wisconsin–Madison